Stay updated on NYX-2925 Efficacy & Safety in Fibromyalgia: Clinical Trial
Sign up to get notified when there's something new on the NYX-2925 Efficacy & Safety in Fibromyalgia: Clinical Trial page.

Latest updates to the NYX-2925 Efficacy & Safety in Fibromyalgia: Clinical Trial page
- Check6 days agoChange DetectedThe Record History page shows a visual redesign; the version history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check27 days agoChange DetectedMajor update to core content: new government funding/operating status notice and version bump to v3.2.0, replacing v3.1.0.SummaryDifference10%

- Check41 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.2%

- Check55 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.6%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.6%

- Check70 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference47%

Stay in the know with updates to NYX-2925 Efficacy & Safety in Fibromyalgia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NYX-2925 Efficacy & Safety in Fibromyalgia: Clinical Trial page.